±¹¸³¾Ï¼¾ÅÍ ±¹Á¦¾Ï´ëÇпø´ëÇб³, Á¦41Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 3°³»ó µ¿½Ã ¼ö»ó
2015³â 06¿ù 29ÀÏ 13½Ã 15ºÐ ÀÔ·Â

[¿Óóµ¥Àϸ®] ±¹¸³¾Ï¼¾ÅÍ ±¹Á¦¾Ï´ëÇпø´ëÇб³ ½Ã½ºÅÛÁ¾¾ç»ý¹°Çаú ±èÇбÕ, ¾Ï°ü¸®Á¤Ã¥Çаú Ãֱͼ±, ÀüÀç°ü ±³¼ö°¡ Áö³­ 6¿ù 19ÀÏ ¼­¿ï ¼Ò°øµ¿ ·Ôµ¥È£ÅÚ¿¡¼­ °³ÃÖµÈ ¡®Á¦41Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ¡¯¿¡¼­ °¢°¢ ±âÃÊ¿ì¼ö³í¹®»ó/±¤µ¿Çмú»óÀ» ¼ö»óÇß´Ù°í ¹àÇû´Ù.

 

½Ã½ºÅÛÁ¾¾ç»ý¹°Çаú ±èÇÐ±Õ ±³¼ö´Â Ç×¾ÏÈĺ¸¹°ÁúÀÇ È¿´ÉÀ» ±¹³» È£¹ß¾ÏÀÎ À§¾Ï/°£¾Ï µ¿¹°¸ðµ¨¿¡¼­ Æò°¡ÇÏ´Â ¹æ¹ý·Ð¿¡ ´ëÇÑ "Preclinical Efficacy Testing for Stomach and Liver Cancers" ´ëÇѾÏÇÐȸÁö ³í¹®À¸·Î ±âÃÊ¿ì¼ö³í¹®»óÀ» ¼ö»óÇÏ¿´´Ù.

 

¾Ï°ü¸®Á¤Ã¥Çаú Ãֱͼ± ±³¼ö´Â ¿ì¸®³ª¶ó¿¡¼­ °£¾Ï ¹ß»ý °íÀ§Ç豺À» ´ë»óÀ¸·Î ÇÏ´Â °£¾Ï °ËÁøÀÇ ºñ¿ë-È¿°ú¼ºÀ» Æò°¡Çϰí, °¡Àå ºñ¿ë-È¿°úÀûÀÎ °ËÁøÀü·«¿¡ ´ëÇÑ ¡°Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea¡± ´ëÇѾÏÇÐȸÁö ³í¹®À¸·Î ±âÃÊ¿ì¼ö³í¹®»óÀ» ¼ö»óÇÏ¿´´Ù.

 

¾Ï°ü¸®Á¤Ã¥Çаú ÀüÀç°ü ±³¼ö´Â ´ëÇѾÏÇÐȸÁöÀÇ ±¹Á¦È­¿¡ ±â¿©ÇÑ °ø·Î¸¦ ÀÎÁ¤¹Þ¾Æ ±Ý¹ø Çмú´ëȸ¿¡¼­ ±¤µ¿Çмú»óÀ» ¼ö»óÇÏ¿´´Ù.

 

´ëÇѾÏÇÐȸ´Â 1958³â ´ëÇѾϿ¬±¸È¸·Î ⸳µÈ ÀÌÈÄ ±âÃÊÀû ¾Ï ¿¬±¸¿Í ÀÓ»óÀû ¿¬±¸ÀÇ ±ÕÇüÀ» ¸ÂÃß¾î ±¹³» ¾Ï ¿¬±¸ ¹× ÇмúȰµ¿ÀÇ È°¼ºÈ­¿¡ ¾ÕÀå¼­ ¿ÔÀ¸¸ç, ´ëÇѾÏÇÐȸÁö´Â 1973³â ´ëÇѾϿ¬±¸È¸ ÀâÁö¸¦ ½ÃÀÛÀ¸·Î Áö¼ÓÀûÀ¸·Î ¹ß°£µÇ¾î ÇöÀç SCIE¿¡ µîÀçµÇ´Â ±¹Á¦ÀûÀÎ ¿µ¹®ÇмúÁöÀÎ ¡°Cancer Research and Treatment¡±·Î ¹ß°£µÇ°í ÀÖ´Ù. ´ëÇѾÏÇÐȸ Çмú´ëȸ´Â Áö³­ 1³â µ¿¾È ´ëÇѾÏÇÐȸÁö¿¡ ¹ßÇ¥µÈ ³í¹® Áß ¿ì¼ö ³í¹®À» ¼±Á¤ÇÏ¿© »óÀ» ¼ö¿©Çϰí ÀÖ´Ù.